158 biostatistics director jobs at 88 companies in United States
2w
Save
Mark Applied
Hide
2w
Director, Biostatistics
Franklin Township or Somerset
$165k-$180k/yrRemoteFull Time
PharmaronHong Kong Stock Exchange: 3759: Provides research, development, and manufacturing services for life sciences.
8+ YOEMaster's degree or higher in biostatistics, statistics, mathematics, or related science; 8+ years of clinical biostatistics experience, clinical trial expertise, SAP authoring, ICH-GCP knowledge, and strong communication skills.
MapLight TherapeuticsNASDAQ: MPLT: Develops targeted drug therapies for central nervous system disorders.
7+ YOEPhD or Master’s with extensive biostatistics experience in clinical trials; regulatory knowledge; proficient in SAS/R; CRO oversight; CNS endpoints.
Sarepta TherapeuticsNASDAQ: SRPT: Develops precision genetic medicines for rare diseases.
9+ YOEPh.D. strongly preferred or Master’s with extensive biostatistics/clinical trials experience; expert in SAS and R; knowledge of FDA/EMA guidelines; leadership in biometrics; ability to mentor.
Vertex PharmaceuticalsNASDAQ: VRTX: Develops and sells prescription drugs for serious genetic diseases.
10+ YOEPh.D. or master's degree in Statistics or Biostatistics; typically 10 years of experience with a Ph.D. or 13 years with a master's degree; expertise in SAS, R, complex statistical methods, drug development, and regulatory interactions.
AltimmuneNASDAQ: ALT: Develops peptide-based therapeutics for obesity and liver diseases.
7+ YOEAdvanced degree in statistics/biostatistics with 7+ years (PhD) or MS with 10+ years clinical trial statistics; proficiency in SAS and/or R, CDISC (SDTM, ADaM); regulatory submission experience and leadership skills.
9+ YOEPhD (9+ years) or MS (11+ years) in statistics/biostatistics or related field; proficiency in SAS, R or Python; experience in clinical trials, regulatory interactions, and leadership; strong communication and organizational skills.
Mineralys TherapeuticsNASDAQ: MLYS: Develops targeted medicines for aldosterone-driven cardiorenal diseases.
PhD+8 years or MS+11 years in biostatistics/statistics for pharma/biotech; experience leading study-level statistics, regulatory submissions (NDA/BLA), CRO oversight, CDISC knowledge, and supervisory experience.
CytokineticsNASDAQ: CYTK: Develops muscle-directed medicines for cardiovascular and neuromuscular diseases.
8+ YOEPh.D. or M.S. in Statistics/Biostatistics with extensive biotech/pharma experience (8+ years for PhD, 12+ for MS). Hands-on clinical trial design/analysis, R proficiency, ML experience, and knowledge of ICH/regulatory guidance.
Beeline Medicines: A clinical-stage biotechnology developing precision therapies for autoimmune and inflammatory diseases.
12+ YOEPhD in biostatistics or related, 12+ years biostatistics experience in pharma/biotech/CRO, regulatory submission experience, expertise in clinical trial design and CDISC standards, proficiency in SAS or R.
10+ YOEPhD in biostatistics/statistics, 10+ years biostatistics experience in pharma/biotech/CRO, expertise in clinical trial methods, regulatory submissions, SAS/R proficiency, and experience with CDISC standards.
Bristol Myers SquibbNew York Stock Exchange: BMY: Develops and distributes innovative medicines for serious diseases.
8+ YOEAdvanced statistics or biostatistics degree; 8+ years' experience with a PhD or 10+ with an MS in pharmaceutical or biotech biostatistics; AI tools, clinical trials, SAS/R, CDISC, GCP, and regulatory expertise.
ExelixisNASDAQ: EXEL: Discovers and commercializes innovative medicines for cancer treatment.
12+ YOELeadership of biostatistics for early-phase oncology trials; MS/PhD in Statistics/Biostatistics with extensive experience (12+ years); experience with clinical biomarkers, omics, CDISC, FDA/EMA/ICH guidelines, managing statisticians, and vendor oversight.
Uniquity Bio: Develops novel therapeutics for immune-mediated diseases.
12+ YOEPhD or MS in biostatistics/statistics or related field, typically 12+ years industry biostatistics experience with leadership, experience across clinical phases and regulatory submissions, strong SAP/protocol authorship, and hands-on R and/or SAS experience.
Bicycle TherapeuticsNASDAQ: BCYC: Developing synthetic peptide medicines for oncology and other diseases.
Senior biostatistics leader with deep oncology clinical trials experience, people management, advanced statistical methods knowledge, regulatory (GCP) experience, and proficiency with R and SAS.
CelcuityNASDAQ: CELC: Developing targeted therapies and diagnostic tests for cancer patients.
12+ YOEMaster's degree in statistics, biostatistics, or related field; 12+ years of clinical trials experience, including 5+ years in oncology; SAS and R expertise; PhD preferred.
Foster City or United States or Thousand Oaks or El Segundo or Parsippany
$238k-$338k/yrHybridFull Time
Gilead SciencesNASDAQ: GILD: Develops and sells medicines for life-threatening infectious diseases.
12+ YOERequires 12+ years with an MS/PhD or 14+ years with a BA/BS, advanced biostatistics expertise, drug development knowledge, regulatory strategy experience, and people leadership skills.
Gilead SciencesNASDAQ: GILD: Develops and sells medicines for life-threatening infectious diseases.
12+ YOESenior people leader in biostatistics with extensive industry experience (typically 12+ years), strong leadership, strategic planning, regulatory knowledge, and ability to lead large, cross-functional statistical programs.
Dyne TherapeuticsNASDAQ: DYN: Developing therapeutics for genetically driven neuromuscular diseases.
12+ YOEPh.D. or Masters in statistics/biostatistics,12+ years pharma/biotech experience,expertise in clinical trial design,CDISC (SDTM/ADaM),advanced SAS (R a plus),regulatory submission experience.
Harmony BiosciencesNASDAQ: HRMY: Develops and commercializes therapies for rare neurological disorders.
15+ YOEPh.D. in biostatistics or related field, 15+ years pharma/biotech drug development experience with leadership, deep expertise in adaptive/Bayesian trial design, regulatory interaction experience, and team leadership.